State of New Jersey Common Pension Fund D’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-218,339
Closed -$1.55M 1682
2022
Q3
$1.55M Sell
218,339
-76,306
-26% -$719K 0.01% 1624
2022
Q2
$2.38M Buy
294,645
+108,686
+58% +$956K 0.01% 1072
2022
Q1
$2.58M Buy
185,959
+83,267
+81% +$1.31M 0.01% 1288
2021
Q4
$2.88M Buy
102,692
+14,989
+17% +$459K 0.01% 1208
2021
Q3
$2.98M Buy
87,703
+17,149
+24% +$620K 0.01% 1079
2021
Q2
$2.88M Buy
70,554
+14,128
+25% +$549K 0.01% 1106
2021
Q1
$2.27M Buy
56,426
+4,445
+9% +$241K 0.01% 1471
2020
Q4
$3.07M Sell
51,981
-3,679
-7% -$190K 0.01% 1043
2020
Q3
$2.71M Sell
55,660
-2,367
-4% -$99.5K 0.01% 950
2020
Q2
$2.81M Buy
+58,027
New +$2.12M 0.01% 922

Other funds holding ADPT

State of New Jersey Common Pension Fund D's ADPT Position: Q4 2022 in Review

State of New Jersey Common Pension Fund D sold out of Adaptive Biotechnologies (ADPT) in Q4 2022, closing a stake of 218,339 shares — an estimated $1.55M sold.

State of New Jersey Common Pension Fund D first reported a position in ADPT in Q2 2020 and held it in 10 quarters. The position peaked at $3.07M in Q4 2020. 223 funds tracked by Wall St. Rank hold ADPT as of Q4 2022.

  • State of New Jersey Common Pension Fund D reported no remaining Adaptive Biotechnologies position as of Q4 2022 after selling out during the quarter.
  • State of New Jersey Common Pension Fund D sold 218,339 Adaptive Biotechnologies shares in Q4 2022, an estimated $1.55M.
  • State of New Jersey Common Pension Fund D first reported a position in Adaptive Biotechnologies in Q2 2020 and held it in 10 quarters.
  • State of New Jersey Common Pension Fund D's Adaptive Biotechnologies position peaked at $3.07M in Q4 2020.
  • 223 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2022.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q4 2022, filed 1 Feb 2023.